MX2021006945A - Anelosomas para suministrar modalidades terapéuticas de reemplazo de proteínas. - Google Patents

Anelosomas para suministrar modalidades terapéuticas de reemplazo de proteínas.

Info

Publication number
MX2021006945A
MX2021006945A MX2021006945A MX2021006945A MX2021006945A MX 2021006945 A MX2021006945 A MX 2021006945A MX 2021006945 A MX2021006945 A MX 2021006945A MX 2021006945 A MX2021006945 A MX 2021006945A MX 2021006945 A MX2021006945 A MX 2021006945A
Authority
MX
Mexico
Prior art keywords
anellosomes
therapeutic modalities
protein replacement
replacement therapeutic
delivering protein
Prior art date
Application number
MX2021006945A
Other languages
English (en)
Spanish (es)
Inventor
Avak Kahvejian
Dhananjay Maniklal Nawandar
Erica Gabrielle Weinstein
Simon Delagrave
Nathan Lawrence Yozwiak
Kevin James Lebo
Fernando Martin Diaz
Ryan D Tedstone
Jared David Pitts
Original Assignee
Flagship Pioneering Innovations V Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations V Inc filed Critical Flagship Pioneering Innovations V Inc
Publication of MX2021006945A publication Critical patent/MX2021006945A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2021006945A 2018-12-12 2019-12-12 Anelosomas para suministrar modalidades terapéuticas de reemplazo de proteínas. MX2021006945A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862778861P 2018-12-12 2018-12-12
US201862778866P 2018-12-12 2018-12-12
PCT/US2019/065963 WO2020123795A2 (en) 2018-12-12 2019-12-12 Anellosomes for delivering protein replacement therapeutic modalities

Publications (1)

Publication Number Publication Date
MX2021006945A true MX2021006945A (es) 2021-08-24

Family

ID=69160356

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021006945A MX2021006945A (es) 2018-12-12 2019-12-12 Anelosomas para suministrar modalidades terapéuticas de reemplazo de proteínas.

Country Status (11)

Country Link
US (1) US20220073950A1 (cg-RX-API-DMAC10.html)
EP (1) EP3894569A2 (cg-RX-API-DMAC10.html)
JP (2) JP2022513459A (cg-RX-API-DMAC10.html)
KR (1) KR20210125990A (cg-RX-API-DMAC10.html)
CN (1) CN114127303A (cg-RX-API-DMAC10.html)
AU (1) AU2019395418A1 (cg-RX-API-DMAC10.html)
BR (1) BR112021010925A2 (cg-RX-API-DMAC10.html)
CA (1) CA3119814A1 (cg-RX-API-DMAC10.html)
IL (1) IL283781A (cg-RX-API-DMAC10.html)
MX (1) MX2021006945A (cg-RX-API-DMAC10.html)
WO (1) WO2020123795A2 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11624061B2 (en) 2017-04-28 2023-04-11 Agrospheres, Inc. Compositions and methods for enzyme immobilization
BR112019022539A2 (pt) 2017-04-28 2020-06-16 Agrospheres, Inc. Composições e métodos para o encapsulamento e entrega escalonável de agorquímicos
BR112020005803A2 (pt) 2017-09-25 2020-12-01 Agrospheres, Inc. composições e métodos para produção e administração moduláveis de produtos biológicos
CA3121528A1 (en) 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
AU2021288320A1 (en) * 2020-06-12 2023-01-19 Flagship Pioneering Innovations V, Inc. Tandem anellovirus constructs
KR20230041686A (ko) * 2020-06-17 2023-03-24 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 아넬로바이러스를 확인 및 특징화하는 방법 및 이의 용도
CA3206361A1 (en) * 2020-12-23 2022-06-30 Flagship Pioneering Innovations V, Inc. In vitro assembly of anellovirus capsids enclosing rna
MX2024004492A (es) * 2021-10-12 2024-05-31 Flagship Pioneering Innovations V Inc Composiciones y metodos de anellovector novedosos.
WO2023069948A1 (en) * 2021-10-18 2023-04-27 Flagship Pioneering Innovations Vii, Llc Dna compositions and related methods
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
US9676828B2 (en) * 2010-06-23 2017-06-13 Deutsches Krebsforschungszentrum Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
CA3066750A1 (en) * 2017-06-13 2018-12-20 Flagship Pioneering Innovations V, Inc. Compositions comprising curons and uses thereof
CA3121528A1 (en) * 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
US20230048858A1 (en) * 2018-12-12 2023-02-16 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering secreted therapeutic modalities
EP3894567A2 (en) * 2018-12-12 2021-10-20 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering intracellular therapeutic modalities

Also Published As

Publication number Publication date
JP2024099833A (ja) 2024-07-25
WO2020123795A3 (en) 2020-08-27
CN114127303A (zh) 2022-03-01
WO2020123795A2 (en) 2020-06-18
KR20210125990A (ko) 2021-10-19
CA3119814A1 (en) 2020-06-18
AU2019395418A1 (en) 2021-06-03
IL283781A (en) 2021-07-29
BR112021010925A2 (pt) 2021-08-31
EP3894569A2 (en) 2021-10-20
US20220073950A1 (en) 2022-03-10
JP2022513459A (ja) 2022-02-08

Similar Documents

Publication Publication Date Title
IL276464A (en) Methods and preparations for administering therapeutic protein
WO2020123795A3 (en) Anellosomes for delivering protein replacement therapeutic modalities
MX2025003235A (es) Composiciones y metodos para el suministro de proteinas de membrana
MX2021006941A (es) Anelosomas para suministrar modalidades terapéuticas intracelulares.
MX2023011657A (es) Composiciones que comprenden curones y usos de los mismos.
JOP20200228A1 (ar) تركيبات وطرق لخفض تعبير البروتين tau
MX2020003190A (es) Degradadores de proteinas y usos de los mismos.
PH12018500086A1 (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
MX2020011133A (es) Composiciones de pienso para animales y usos de las mismas.
MX2022012374A (es) Composiciones multi-suplementos.
MX2020007166A (es) Composiciones para modular la expresion de sod-1.
WO2020123773A3 (en) Anellosomes for delivering secreted therapeutic modalities
MX377141B (es) Composiciones y metodos para modular la expresion de pkk.
MX2016010951A (es) Proteinas de fc multimericas.
SG10201808063PA (en) Compositions for modulating ataxin 2 expression
PH12017501483A1 (en) Bicyclic heterocycles as fgfr4 inhibitors
MX2020004118A (es) Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas.
PH12019502694A1 (en) Anti-trkb antibodies
MX2020013389A (es) Composiciones de terlipresina y usos de las mismas.
CY1125113T1 (el) Συνθεσεις και μεθοδοι για χρηση στην αγωγη της ομοκυστινουριας
PH12017501601A1 (en) Use of isolated fractions of mastic gum for treating optic neuropathy
ZA202105101B (en) Peptides for treatment and prevention of diabetes and associated disorders
MX2018011193A (es) Proteinas derivadas de alfa-1-microglobulina novedosas y su uso.
MA40642A (fr) Nouveaux dérivés peptidiques et leurs utilisations